Chong Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chong Kim has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Behnum Ali Habibi
Case Western Reserve University/The MetroHealth System
3 shared publications Maria Grabnar
Case Western Reserve University/MetroHealth
3 shared publications- Travis Cleland
Case Western Reserve University School of Medicine
3 shared publications Alaa Abd-Elsayed
University of Wisconsin School of Medicine and Public Health
2 shared publications- Nitin B. Jain
Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, USA; Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA; Department of Orthopaedic Surgery, The University of Texas Southwestern Medical Center, Dallas, TX, USA
2 shared publications - Richard D. Wilson
The MetroHealth Rehabilitation Institute MetroHealth System Case Western Reserve University School of Medicine Cleveland Ohio
2 shared publications
Latest Publications
- 18 August 2026
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
Ventral Column Spinal Cord Stimulation for Pain Management
Spinal cord stimulation (SCS) is a form of neuromodulation that delivers electrical impulses to the spinal cord, altering pain signals to provide relief from chronic pain. Since its introduction in the 1960s, SCS has primarily targeted the dorsal columns of the spinal cord. While SCS has proven effective for many neuropathic pain conditions, its limitations have driven exploration of alternative anatomical targets for electrical stimulation. Work in the 1970’s suggested that ventral column spinal cord stimulation (VC-SCS) might offer superior pain relief by targeting the spinothalamic tracts (Hoppenstein, 1975). Several decades later, a study reported successful use of VC-SCS for visceral pain in 26 patients (Baranidharan et al, 2014). A recent case report demonstrated comparable outcomes between dorsal and ventrolateral SCS for post-laminectomy syndrome (van Acker and Kim, 2023). Noordin et al (2023) reported meaningful improvements in pain and function using VC-SCS in a patient with chronic visceral pain. Finally, Sheen et al (2024) demonstrated pain relief for 12 months in a patient with VC-SCS. VC-SCS represents a promising investigational approach for pain syndromes refractory to traditional dorsal column stimulation. Ongoing research should focus on refining techniques and addressing critical knowledge gaps regarding patient selection and the durability of outcomes.
- 18 August 2026
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
Ventral Column Spinal Cord Stimulation for Pain Management
Spinal cord stimulation (SCS) is a form of neuromodulation that delivers electrical impulses to the spinal cord, altering pain signals to provide relief from chronic pain. Since its introduction in the 1960s, SCS has primarily targeted the dorsal columns of the spinal cord. While SCS has proven effective for many neuropathic pain conditions, its limitations have driven exploration of alternative anatomical targets for electrical stimulation. Work in the 1970’s suggested that ventral column spinal cord stimulation (VC-SCS) might offer superior pain relief by targeting the spinothalamic tracts (Hoppenstein, 1975). Several decades later, a study reported successful use of VC-SCS for visceral pain in 26 patients (Baranidharan et al, 2014). A recent case report demonstrated comparable outcomes between dorsal and ventrolateral SCS for post-laminectomy syndrome (van Acker and Kim, 2023). Noordin et al (2023) reported meaningful improvements in pain and function using VC-SCS in a patient with chronic visceral pain. Finally, Sheen et al (2024) demonstrated pain relief for 12 months in a patient with VC-SCS. VC-SCS represents a promising investigational approach for pain syndromes refractory to traditional dorsal column stimulation. Ongoing research should focus on refining techniques and addressing critical knowledge gaps regarding patient selection and the durability of outcomes.
- 11 July 2026
- Published by Springer Nature
- p. 49-56
Non-Pharmacological Management
- 11 July 2026
- Published by Springer Nature
- p. 137-149
Cryotherapy of the Trigeminal Nerve
- 3 July 2025
- Published by Springer Nature
- p. 249-262
Enhancing Practice Value
- 31 July 2024
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 104 (4) , 335-340
Impact of Body Mass Index on Opioid Prescriptions After Lumbar Spine Surgery
Objective: This study aimed to evaluate the association between body mass index and postoperative opioid use within 2 yrs after lumbar spine surgery using a national database. Methods: TriNetX, a national network of deidentified patient records, was retrospectively queried from 2003 to 2021 using International Classification of Disease 10, Current Procedural Terminology, and Veterans Affairs codes. Propensity score matching analysis was performed based on demographics, comorbidities, anxiety disorders, and mood disorders. Results: A total of 21,997 patients were included in our analysis. Patients with body mass index ≥ 30 were more likely to be prescribed opioids postoperatively (odds ratio: 1.30; 95% confidence interval: 1.18–1.42). Patients with body mass index ≥ 40 were more likely to be prescribed opioids when compared to patients with body mass index < 30 (odds ratio: 1.94; 95% confidence interval: 1.48–2.56), body mass index 30–34.9 (odds ratio: 2.06; 95% confidence interval: 1.57–2.70), body mass index 35–39.9 (odds ratio: 1.50; 95% confidence interval: 1.13–2.00), and body mass index < 40 (odds ratio: 2.06; 95% confidence interval: 1.57–2.70). The body mass index ≥ 40 group had an increased number of opioid prescriptions within 2 yrs after lumbar surgery compared to patients with body mass index 30–34.9 (P = 0.0113) and body mass index < 30 (P = 0.0018). Conclusions: Opioid prescription after lumbar spine surgery is associated with an elevated body mass index. Patients with class III obesity seem to be at the highest risk of increased opioid prescriptions after lumbar surgery. Physicians should consider the patient’s body mass index when deciding postoperative pain management.
- 31 July 2024
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 104 (4) , 335-340
Impact of Body Mass Index on Opioid Prescriptions After Lumbar Spine Surgery
Objective: This study aimed to evaluate the association between body mass index and postoperative opioid use within 2 yrs after lumbar spine surgery using a national database. Methods: TriNetX, a national network of deidentified patient records, was retrospectively queried from 2003 to 2021 using International Classification of Disease 10, Current Procedural Terminology, and Veterans Affairs codes. Propensity score matching analysis was performed based on demographics, comorbidities, anxiety disorders, and mood disorders. Results: A total of 21,997 patients were included in our analysis. Patients with body mass index ≥ 30 were more likely to be prescribed opioids postoperatively (odds ratio: 1.30; 95% confidence interval: 1.18–1.42). Patients with body mass index ≥ 40 were more likely to be prescribed opioids when compared to patients with body mass index < 30 (odds ratio: 1.94; 95% confidence interval: 1.48–2.56), body mass index 30–34.9 (odds ratio: 2.06; 95% confidence interval: 1.57–2.70), body mass index 35–39.9 (odds ratio: 1.50; 95% confidence interval: 1.13–2.00), and body mass index < 40 (odds ratio: 2.06; 95% confidence interval: 1.57–2.70). The body mass index ≥ 40 group had an increased number of opioid prescriptions within 2 yrs after lumbar surgery compared to patients with body mass index 30–34.9 (P = 0.0113) and body mass index < 30 (P = 0.0018). Conclusions: Opioid prescription after lumbar spine surgery is associated with an elevated body mass index. Patients with class III obesity seem to be at the highest risk of increased opioid prescriptions after lumbar surgery. Physicians should consider the patient’s body mass index when deciding postoperative pain management.
- 8 May 2024
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 25 (9) , 584-586
Basic radiation safety practices: observed radiation doses in a phantom model
Claire Cooper, MD, Ryan Fisher, PhD, Nafis Eghrari, Matthew Chen, Sajal Kulhari, Maryam Hosseini, MD, Chong Kim, MD; Basic radiation safety Practices-Obser
- 8 May 2024
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 25 (9) , 584-586
Basic radiation safety practices: observed radiation doses in a phantom model
Claire Cooper, MD, Ryan Fisher, PhD, Nafis Eghrari, Matthew Chen, Sajal Kulhari, Maryam Hosseini, MD, Chong Kim, MD; Basic radiation safety Practices-Obser
- Open Access
- 30 June 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (7) , 1012
Prescription Trends in Complex Regional Pain Syndrome: A Retrospective Case–Control Study
Objective: The objective of this study was to evaluate discrepancies in prescription trends for analgesic medications in complex regional pain syndrome (CRPS) patients based on recommendations in the literature. Design: We conducted a retrospective case–control study. Subjects: A total of 2510 CRPS patients and 2510 demographic-matched controls participated in this study. Methods: The SlicerDicer feature in Epic was used to find patients diagnosed with CRPS I or II between January 2010 and November 2022. An equal number of age-, gender-, and race-matched controls without a CRPS diagnosis were retracted from Epic. General and CRPS-associated prescription frequencies for the following classes were retrieved for both cases and controls: benzodiazepines, bisphosphonates, calcitonin, capsaicin, neuropathic pain medications, NSAIDs, opioids, and steroids. Results: A total of 740 (29%) CRPS patients and 425 (17%) controls were prescribed benzodiazepines (95% CI 0.1–0.15), 154 (6.1%) CRPS patients and 52 (2.1%) controls were prescribed capsaicin (95% CI 0.03–0.05), 1837 (73%) CRPS patients and 927 (37%) controls were prescribed neuropathic pain medications (95% CI 0.05–0.34), 1769 (70%) CRPS patients and 1217 (48%) controls were prescribed opioids (95% CI 0.19–0.25), 1095 (44%) CRPS patients and 1217 (48%) controls were prescribed steroids (95% CI 0.08–0.14), and 1638 (65%) CRPS patients and 1765 (70%) controls were prescribed NSAIDs (95% CI −0.08–0.02), p < 0.001 for all classes. With CRPS-associated prescriptions, (95% CI 0.05–0.16, p < 0.001) more CRPS patients were prescribed opioids (N = 398, 59%) than controls (N = 327, 49%). Conclusions: CRPS is difficult to treat with significant variance in suggested treatment modalities. Based on the results of our study, there is a divergence between some published recommendations and actual practice.
- 30 June 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (7) , 1012
Open AccessPrescription Trends in Complex Regional Pain Syndrome: A Retrospective Case–Control Study
Objective: The objective of this study was to evaluate discrepancies in prescription trends for analgesic medications in complex regional pain syndrome (CRPS) patients based on recommendations in the literature. Design: We conducted a retrospective case–control study. Subjects: A total of 2510 CRPS patients and 2510 demographic-matched controls participated in this study. Methods: The SlicerDicer feature in Epic was used to find patients diagnosed with CRPS I or II between January 2010 and November 2022. An equal number of age-, gender-, and race-matched controls without a CRPS diagnosis were retracted from Epic. General and CRPS-associated prescription frequencies for the following classes were retrieved for both cases and controls: benzodiazepines, bisphosphonates, calcitonin, capsaicin, neuropathic pain medications, NSAIDs, opioids, and steroids. Results: A total of 740 (29%) CRPS patients and 425 (17%) controls were prescribed benzodiazepines (95% CI 0.1–0.15), 154 (6.1%) CRPS patients and 52 (2.1%) controls were prescribed capsaicin (95% CI 0.03–0.05), 1837 (73%) CRPS patients and 927 (37%) controls were prescribed neuropathic pain medications (95% CI 0.05–0.34), 1769 (70%) CRPS patients and 1217 (48%) controls were prescribed opioids (95% CI 0.19–0.25), 1095 (44%) CRPS patients and 1217 (48%) controls were prescribed steroids (95% CI 0.08–0.14), and 1638 (65%) CRPS patients and 1765 (70%) controls were prescribed NSAIDs (95% CI −0.08–0.02), p < 0.001 for all classes. With CRPS-associated prescriptions, (95% CI 0.05–0.16, p < 0.001) more CRPS patients were prescribed opioids (N = 398, 59%) than controls (N = 327, 49%). Conclusions: CRPS is difficult to treat with significant variance in suggested treatment modalities. Based on the results of our study, there is a divergence between some published recommendations and actual practice.
- 1 January 2022
- Published by Springer Nature
- p. 261-265
Craniofacial Pain: Occipital Neuralgia and Nerve Block
- 1 January 2022
- Published by Springer Nature
- p. 261-265
Craniofacial Pain: Occipital Neuralgia and Nerve Block
- 1 January 2022
- Published by Springer Nature
- p. 257-260
Craniofacial Pain: Trigeminal Neuralgia
- Open Access
- 16 December 2021
- Published by Ochsner Journal in Ochsner Journal
- Vol. 21 (4) , 358-363
Impact of Lavender on Pain and Anxiety Levels Associated With Spine Procedures
Background: To reduce pain and anxiety associated with interventional pain procedures, sedation is often used, with benzodiazepines, opioids, and propofol the most commonly used classes of drugs for sedation. However, patient coherence and ability to communicate procedural pain and abnormal sensations help prevent adverse outcomes. Therefore, discovering alternative therapies to mitigate the anxiety and pain associated with these procedures and to minimize risk is important. The aim of our study was to investigate whether lavender has an effect on pain and anxiety associated with lumbar epidural steroid injections and lumbar medial branch blocks. Methods: In this randomized controlled study, 54 subjects were randomly assigned to 1 of 3 intervention groups, and 46 patients were included in the final analysis: experimental lavender group (n=17), control almond oil group (n=15), and placebo sterile water group (n=14). Patients wore a mask infused with either lavender, almond oil, or water for 5 minutes prior to and during their procedure. Patients rated their anxiety using the State-Trait Anxiety Inventory prior to and after the procedure based on how they felt during the procedure. Patients rated their pain according to the numerical rating scale. Outcome measures were a comparison of pain among the 3 groups and a comparison of the change in anxiety before and after the procedure among the 3 groups. Results: The lavender group demonstrated the highest mean change in anxiety scores (9.9) compared to almond oil (5.3) and water (3.6) preprocedurally vs postprocedurally. The lavender group also reported the lowest mean pain level (3.8) compared to almond oil (5.6) and water (5.6). However, none of the differences between groups showed statistical significance at the P<0.05 level. Conclusion: Lavender may have a clinically beneficial effect on anxiety levels and pain reduction.
- 16 December 2021
- Published by Ochsner Journal in Ochsner Journal
- Vol. 21 (4) , 358-363
Open AccessImpact of Lavender on Pain and Anxiety Levels Associated With Spine Procedures
Background: To reduce pain and anxiety associated with interventional pain procedures, sedation is often used, with benzodiazepines, opioids, and propofol the most commonly used classes of drugs for sedation. However, patient coherence and ability to communicate procedural pain and abnormal sensations help prevent adverse outcomes. Therefore, discovering alternative therapies to mitigate the anxiety and pain associated with these procedures and to minimize risk is important. The aim of our study was to investigate whether lavender has an effect on pain and anxiety associated with lumbar epidural steroid injections and lumbar medial branch blocks. Methods: In this randomized controlled study, 54 subjects were randomly assigned to 1 of 3 intervention groups, and 46 patients were included in the final analysis: experimental lavender group (n=17), control almond oil group (n=15), and placebo sterile water group (n=14). Patients wore a mask infused with either lavender, almond oil, or water for 5 minutes prior to and during their procedure. Patients rated their anxiety using the State-Trait Anxiety Inventory prior to and after the procedure based on how they felt during the procedure. Patients rated their pain according to the numerical rating scale. Outcome measures were a comparison of pain among the 3 groups and a comparison of the change in anxiety before and after the procedure among the 3 groups. Results: The lavender group demonstrated the highest mean change in anxiety scores (9.9) compared to almond oil (5.3) and water (3.6) preprocedurally vs postprocedurally. The lavender group also reported the lowest mean pain level (3.8) compared to almond oil (5.6) and water (5.6). However, none of the differences between groups showed statistical significance at the P<0.05 level. Conclusion: Lavender may have a clinically beneficial effect on anxiety levels and pain reduction.